Amanote Research
Register
Sign In
P1.17-09 V30 May Better Predict Radiation Pneumonitis After Intensity-Modulated Radiation Therapy for Lung Cancer
Journal of Thoracic Oncology
- United States
doi 10.1016/j.jtho.2018.08.1042
Full Text
Open PDF
Abstract
Available in
full text
Categories
Medicine
Oncology
Respiratory Medicine
Pulmonary
Date
October 1, 2018
Authors
Y. Meng
C. Yu
X. Tang
W. Wang
C. Jiang
F. Kong
H. Yang
Publisher
Elsevier BV
Related search
P1.17-20 Excluding PTV From Lung Volume May Better Predict Radiation Pneumonitis for IMRT Treated Lung Cancer Patients
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Dose–Volume Metrics Associated With Radiation Pneumonitis After Stereotactic Body Radiation Therapy for Lung Cancer
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Intensity-Modulated Radiation Therapy
Intensity‐Modulated Radiation Therapy
Medical Physics
Medicine
Nuclear Medicine
Radiology
Imaging
Biophysics
Health-Related Quality-Of-Life After External Beam Radiation Therapy for Localized Prostate Cancer: Intensity-Modulated Radiation Therapy Versus Conformal Radiation Therapy
Prostate Cancer and Prostatic Diseases
Cancer Research
Oncology
Urology
Impact of Pretreatment Interstitial Lung Disease on Radiation Pneumonitis and Survival After Stereotactic Body Radiation Therapy for Lung Cancer
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Pretreatment Factors Influencing Radiation Pneumonitis After Stereotactic Body Radiation Therapy in the Treatment of Lung Cancer
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Cost of Intensity-Modulated Radiation Therapy for Older Patients With Stage III Lung Cancer
Annals of the American Thoracic Society
Pulmonary
Respiratory Medicine
Pretreatment Factors Influencing Radiation Pneumonitis After Stereotactic Body Radiation Therapy in the Treatment of Lung Cancer
Cureus
